Endoscopic Fluorescence-Guided Surgery for Sinonasal Cancer Using an Antibody-Dye Conjugate

Zachary P Hart1, Naoki Nishio1,2, Giri Krishnan1,3

  • 1Department of Otolaryngology, Stanford University School of Medicine, Stanford, California, U.S.A.

The Laryngoscope
|December 20, 2019
PubMed
Abstract

Insights

Endoscopic fluorescence-guided surgery (FGS) shows promise for improving sinonasal squamous cell carcinoma resection. This technique effectively identified tumor tissue in a human sinus model, aiding in achieving clear surgical margins.

Area of Science:

  • Otolaryngology
  • Surgical Oncology
  • Medical Imaging

Background:

  • Endoscopic resection is standard for sinonasal squamous cell carcinoma.
  • Achieving clear resection margins remains a surgical challenge.

Purpose of the Study:

  • To evaluate the feasibility of endoscopic fluorescence-guided surgery (FGS) for improving surgical resection in a human sinus model.
  • To assess the effectiveness of near-infrared (NIR) fluorescence detection in identifying tumor tissue.

Main Methods:

  • A fluorescence endoscope for NIR detection was tested in phantom and human sinus models.
  • Tumor models were created using mouse-derived squamous cell carcinoma.
  • Panitumumab-IRDye800CW was administered intravenously, and fluorescence metrics (MFI, TBR) were analyzed.

Main Results:

  • A 10-mm diameter endoscope yielded significantly higher fluorescence intensity than a 4-mm scope.
  • Optimal tumor detection was achieved at a 1-cm working distance in the human sinus model.
  • Clinically acceptable tumor-to-background ratios (TBRs) were obtained, discriminating tumor from normal tissue.

Conclusions:

  • Endoscopic FGS demonstrates potential for identifying residual tumor during surgery.
  • This technique may enhance the precision of sinonasal cancer resection.
  • Further validation in clinical settings is warranted.

Related Concept Videos